Mupirocin
These highlights do not include all the information needed to use MUPIROCIN OINTMENT safely and effectively. See full prescribing information for MUPIROCIN OINTMENT.MUPIROCIN ointment, for topical useInitial U.S. Approval: 1987
Approved
Approval ID
17c7a199-2e21-4060-9543-3f538108e6b0
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 16, 2018
Manufacturers
FDA
Central Texas Community Health Centers
DUNS: 079674019
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Mupirocin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code76413-158
Application NumberANDA090480
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mupirocin
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 12, 2017
FDA Product Classification
INGREDIENTS (3)
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
MUPIROCINActive
Quantity: 20 mg in 1 g
Code: D0GX863OA5
Classification: ACTIB
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5P
Classification: IACT